T1-weighted dynamic contrast-enhanced MR evaluation of different stages of neurocysticercosis and its relationship with serum MMP-9 expression

American Journal of Neuroradiology

Volumn 34, Issue 5, 2013, Pages 997-1003

  Gupta, Rakesh K ^a   Awasthi, R ^a   Garg, R K ^b   Kumar, N ^b   Gupta, P K ^b   Singh, A K ^a   Sahoo, P ^c   Paliwal, V K ^a   Prasad, K N ^a   Pandey, C M ^a   Rathore, R K S ^c  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GADODIAMIDE; GELATINASE B;

ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN BLOOD VOLUME; BRAIN CALCIFICATION; BRAIN EDEMA; BRAIN PERFUSION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HUMAN; IMAGE PROCESSING; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PIG FARMING; PROTEIN EXPRESSION; SEIZURE; TONIC CLONIC SEIZURE; VOXEL BASED MORPHOMETRY;

BIOLOGICAL MARKERS; CONTRAST MEDIA; EPILEPSY; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; MATRIX METALLOPROTEINASE 9; NEUROCYSTICERCOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC;

EID: 84878498960     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3346     Document Type: Article

References (20)

1. Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras J, eds. Cysticercosis of the Central Nervous System. Springfield, Ill: Charles C. Thomas; 1983:27-54
2. Alvarez JI, Teale JM. Evidence of differential changes of junctional complex proteins in murine neurocysticercosis dependent upon CNS vasculature. Brain Res 2007;1169:98-111 (Pubitemid 47374095)
3. Alvarez JI, Teale JM. Breakdown of the blood brain barrier and blood-cerebrospinal fluid barrier is associated with differential leukocyte migration in distinct compartments of the CNS during the course of murine NCC. J Neuroimmunol 2006;173:45-55
4. Chawla S, Husain N, Kumar S, et al. Correlative MR imaging and histopathology in porcine neurocysticercosis. J Magn Reson Imaging 2004;20:208-15 (Pubitemid 38970928)
5. Sikasunge CS, Johansen MV, Phiri IK, et al. The immune response in Taenia solium neurocysticercosis in pigs is associated with astrogliosis, axonal degeneration and altered blood-brain barrier permeability. Vet Parasitol 2009;160:242-50
6. Gupta RK, Awasthi R, Rathore RK, et al. Understanding epileptogenesis in calcified neurocysticercosis with perfusion MRI. Neurology 2012;28:78:618-25
7. Prasad A, Gupta RK, Pradhan S, et al. What triggers seizures in neurocysticercosis? A MRI-based study in pig farming community from a district of North India. Parasitol Int 2008;57:166-71
8. Parks WC, Wilson CL, Lopez-Boado YS. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004;4:617-29 (Pubitemid 39025047)
9. Verma A, Prasad KN, Nyati KK, et al. Association of MMP-2 and MMP-9 with clinical outcome of neurocysticercosis. Parasitology 2011;138:1423-28
10. Haris M, Husain N, Singh A, et al. Dynamic contrast-enhanced (DCE) derived transfer coefficient (ktrans) is a surrogate marker of matrix metalloproteinase 9 expression in brain tuberculomas. J Magn Reson Imaging 2008;28:588-97
11. Singh A, Haris M, Rathore D, et al. Quantification of physiological and hemodynamic indices using T(1) dynamic contrast enhanced MRI in intracranial mass lesions. J Magn Reson Imaging 2007;26:871-80 (Pubitemid 47548145)
12. Jackson A. Imaging microvascular structure with contrast enhanced MRI. Br J Radiol 2003;76:159-73
13. Del Brutto OH, Rajshekhar V, White AC Jr, et al. Proposed diagnostic criteria for neurocysticercosis. Neurology 2001;57:177-83
14. Singh A, Rathore RK, Haris M, et al. Improved bolus arrival time and arterial input function estimation for tracer kinetic analysis in DCE-MRI. J Magn Reson Imaging 2009;29:166-76
15. Garcia HH, Del Brutto OH. Imaging findings in neurocysticercosis. Acta Trop 2003;87:71-78 (Pubitemid 36629485)
16. Chang KH, Lee JH, Han MH, et al. The role of contrast-enhanced MR imaging in the diagnosis of neurocysticercosis. AJNR Am J Neuroradiol 1991;12:509-12
17. Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21:7724-32 (Pubitemid 32904971)
18. Gupta RK, Kumar R, Chawla S, et al. Demonstration of scolex within calcified cysticercus cyst: its possible role in the pathogenesis of perilesional edema. Epilepsia 2002;43:1502-08 (Pubitemid 35429768)
19. Awasthi R, Pandey CM, Sahoo P, et al. Dynamic contrast-enhanced magnetic resonance imaging-derived kep as a potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study. J Comput Assist Tomogr 2012;36:125-30
20. Awasthi R, Rathore RK, Soni P, et al. Discriminant analysis to classify glioma grading using dynamic contrast-enhanced MRI and immunohistochemical markers. Neuroradiology 2012;54:205-13